Page last updated: 2024-08-26

peptide elongation factor 2 and Cardiomegaly

peptide elongation factor 2 has been researched along with Cardiomegaly in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baksh, S; Chan, AY; Dolinsky, VW; Dyck, JR; Light, PE; Soltys, CL; Viollet, B1
Abel, ED; Holzenberger, M; Kim, J; LeRoith, D; Litwin, SE; Sena, S; Sloan, C; Soto, J; Theobald, HA; Wayment, BE; Wende, AR1
Chan, AY; Dyck, JR1
Holtz, J; Jäger, D; Müller, SP; Müller-Werdan, U; Pönicke, K; Werdan, K1

Reviews

1 review(s) available for peptide elongation factor 2 and Cardiomegaly

ArticleYear
Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.
    Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Cardiomegaly; Energy Metabolism; Enzyme Activation; Humans; Multienzyme Complexes; Peptide Elongation Factor 2; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Signal Transduction

2005

Other Studies

3 other study(ies) available for peptide elongation factor 2 and Cardiomegaly

ArticleYear
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
    The Journal of biological chemistry, 2008, Aug-29, Volume: 283, Issue:35

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Mice; Multienzyme Complexes; Myocytes, Cardiac; Peptide Elongation Factor 2; Phenylephrine; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Stilbenes; Transcription, Genetic

2008
Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Molecular endocrinology (Baltimore, Md.), 2008, Volume: 22, Issue:11

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cell Enlargement; Cells, Cultured; Male; Mice; Mice, Knockout; Models, Cardiovascular; Myocardial Contraction; Myocytes, Cardiac; Peptide Elongation Factor 2; Physical Exertion; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; Receptor, Insulin; Ribonucleotides; Signal Transduction; Swimming

2008
The impact of insulin-like growth factor-1 on the pattern of cardiac elongation factor-2 variants in a model of overload.
    Molecular and cellular biochemistry, 2002, Volume: 229, Issue:1-2

    Topics: Animals; Apoptosis; Body Weight; Cardiomegaly; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Genetic Variation; Heart; Hemodynamics; Hypertension; Insulin-Like Growth Factor I; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Elongation Factor 2; Rats; Rats, Wistar

2002